natalizumab
biogen
['#ms ', 'natalizumab']
mariottini, florence: comparing ahsct to natalizumab. trend for less pira in the ahsct group.
higher edds at start and higher age were predictive .so coming in too late with ntz may explain results. and the bbb penetration effect by ahsct may play a role.
#ean2023 #ms 
Professor Dr Bart Van Wijmeersch
Neurologist, Immunologist
#MultipleSclerosis Expert
@ University MS Centre, Hasselt-Pelt, Belgium